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Abstract The otorhinolaryngological (ORL) manifesta-
tions of Human Immunodeficiency virus (HIV) are com-
mon, but remain poorly characterized among children of
Sub-Saharan Africa, where 90% of new pediatric infections
occur. Our objective was to compare ORL findings and
hearing in HIV-positive and -negative children of Luanda,
Angola, using a comparative study of 78 outpatients from
the HIV polyclinic and of 78 age- and sex-matched controls
in a pediatric hospital with interview, general and ORL
examination, brainstem auditory evoked potentials, and at
age[5 years pure tone open-air audiometry. ORL pathology
emerged in 92% of HIV-positive and 78% (p = 0.02) of
control children. HIV-associated ORL findings comprised
dental caries (56 vs. 32%; p = 0.0009), cervical lymphad-
enopathy [1 cm (45 vs. 10%; p \ 0.0001), facial skin
lesions (32 vs. 5.1%; p \ 0.0001), chronic suppurative otitis
media (26 vs. 3.8%; p = 0.0002), dry tympanic membrane
perforations (9 vs. 1%; p = 0.03), tonsils of Mallampati
score 0–1 (87 vs. 64%; p = 0.0009), and bilateral hearing
loss of[25 dB (13 vs. 1%; p = 0.009). Other HIV-associ-
ated characteristics included ear pain (44 vs. 27%;
p = 0.006), earlier otorrhea episodes (34 vs. 17%;
p = 0.004), tuberculosis (29 vs. 2.6%; p \ 0.0001), and
pneumonia (22 vs. 2.6%; p = 0.0003). ORL pathology
appeared usual in both HIV-positive and -negative children.
However, the overall high frequency and severity of the
findings among the HIV-positive children require regular
inclusion of the ORL area in these children’s clinical
evaluation.
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Introduction
The otorhinolaryngological (ORL) manifestations of the
human immunodeficiency virus (HIV) are various and
emerge during disease progression in the vast majority of
infected children [1–3]. Transmitted through body fluids
and secretions and infecting specific subsets of leukocytes,
HIV leads to progressive deterioration of the host’s cell-
mediated immune system, and leads to lymphoid changes
and opportunistic infections; these are often encountered in
the head and neck area.
The profile of ORL findings among pediatric HIV
patients is especially characterized by chronic or recurrent
otitis media and enlargement of cervical lymph nodes [1, 3,
4]. In addition, HIV involvement of the intraparotid and
pharyngeal lymphoid tissue may lead to marked hypertro-
phy of these structures [5–7], whereas in the orofacial
region, widespread lesions of viral and fungal infections, as
well as dental caries, may occur [1, 3, 8]. HIV-infected
children may also suffer from hearing loss of either
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peripheral or central origin [9, 10]. However, several of
these findings may frequently emerge among HIV-negative
children as well, particularly in developing countries,
where ORL illnesses are common.
Worldwide, there are more than two million HIV-posi-
tive children, and over 90% of new infections occur in Sub-
Saharan Africa [11]. In Angola, a southwestern African
country with a relatively low but constantly growing HIV
rate (2.1% of the adult population), the number of pediatric
HIV patients is steadily increasing, reaching 17,000 in
2007 [12]. In developing countries, improved access to
antiretroviral (ARV) therapy has raised the life-expectancy
of HIV patients, emphasizing the role of recognition and
treatment of even less severe manifestations of the disease,
such as those concerning the ORL area.
This study was conducted to define and compare the
ORL findings and hearing in HIV-positive and -negative
children in Luanda, the capital of Angola.
Children and methods
Seventy-eight children attending an HIV consultation at the
Pediatric Hospital (Hospital Pediátrico) of Luanda, Angola,
and 78 age- and sex-matched outpatients (controls) from
the surgical and general pediatric polyclinics of the hospital
participated in the study during January–July 2008. The
hospital’s ethics committee accepted the study protocol,
and an informed consent was obtained from the children’s
guardians.
All children underwent a structured interview, physical
examination, ORL status including pneumatic otoscopy,
and hearing screening. Any abnormal finding in the ORL
status, including caries, was categorized as ‘‘ORL pathol-
ogy’’. Children presenting at least one tooth with a decayed
surface were diagnosed as having caries. HIV was diag-
nosed at the hospital’s HIV polyclinic by a specific anti-
body-detecting test (Hexagon HIV Human, Wiesbaden,
Germany), and children with signs or symptoms indicative
of WHO clinical disease stage 3 or 4 [13] were defined as
having advanced disease. Children with weight-for-age\-
2 SD of the mean were regarded as malnourished. In
diagnosis of pneumonia, chest X-ray was available in two
cases; otherwise, diagnosis was based on a combination of
cough, fever, tachypnea, and crepitation in auscultation.
Tonsil size was classified according to the Mallampati
score (0, tonsils fit within the tonsillar fossa; 1?, tonsils
\25% of space between pillars; 2?, tonsils 25–50% of
space between pillars; 3?, tonsils 50–75% of space
between pillars; 4?, tonsils [75% of space between
pillars).
The child was diagnosed as having acute otitis media
(AOM) if he or she manifested in otoscopy a red or opaque
tympanum without mobility, combined with at least one of
the following symptoms: ear pain, fever, rhinorrhea, cough.
In cases of otorrhea, chronic suppurative otitis media
(CSOM) was diagnosed if the child’s ear discharge had
persisted for at least 2 weeks; otherwise, the case was
defined as AOM. An ear-discharge smear was obtained
with a sterile cotton swab from the external ear canal of 17
HIV-positive and one control child with CSOM. The
samples were Gram-stained, cultured under aerobic con-
ditions, and analyzed following the norms of the National
Committee for Clinical Laboratory Standards.
The brainstem auditory evoked potentials, measured at
40, 60, and 80 dB (Bera MADSEN Octavus system v.
2.001, Windows XP/2000 compatible; GN Otometrics,
Denmark), were considered normal when showing a
response at 40 dB. Moderate hearing loss was diagnosed
with a response threshold at 60 dB, severe hearing loss at
80 dB, and profound hearing loss when the response was
lacking. Additionally, pure-tone air-conduction audiometry
(Midimate 622 Clinical/Diagnostic Audiometer; Madsen
Electronics, Denmark), screening at frequencies of 125,
250, 500, 1,000, 2,000, 4,000, and 8,000 Hz without
masking tone, was performed for children over 5 years.
The average hearing threshold at 500–4,000 Hz was
counted and scaled according to WHO standards: B25 dB
for normal hearing and 26–40 dB for slight, 41–60 dB for
moderate, 61–80 dB for severe, and at least 81 dB for
profound hearing loss.
In data analysis, performed with Statview program (v.
5.0.1, SAS Institute Inc., USA), p-values were calculated
with Chi square, Fisher’s exact test, and Mann–Whitney
U test. p values \0.05 were considered statistically
significant.
Results
Table 1 shows the demographic data of HIV-positive and
control children. Thirty-six (46%) HIV-infected children
were on ARV treatment, and 41 (53%) had advanced disease.
Twenty-four (59%) of the children with advanced disease
were on ARV medication. Compared with control children,
HIV children had more often received complete vaccinations
(p = 0.02) and suffered from tuberculosis (p \ 0.0001) and
otorrhea episodes (p = 0.004). HIV-positive children also
more often presented with ear pain (p = 0.006), enlarged
liver (p = 0.007), pneumonia (p = 0.0003), and current
treatment with antibiotics (p \ 0.0001).
ORL pathology was detected in 72 (92%) HIV-positive
and 61 (78%; p = 0.02) control children. The ORL find-
ings associated with HIV comprised dental caries (p =
0.0009), cervical lymphadenopathy [1 cm (p \ 0.0001),
facial skin lesions (folliculitis, molluscum contagiosum,
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eczema; p \ 0.0001), CSOM (p \ 0.0001), nondischarg-
ing tympanic membrane perforations (p = 0.03), and small
tonsils (p = 0.0009) (Table 2). In addition, the following
conditions were detected among HIV-positive subjects
(one case of each): gingivitis, sinusitis, oral petecchiae,
facial lipoatrophy, and cervical abscess (9 cm in diameter;
surgically drained). One HIV-positive boy had a cystic,
clear-blue tumor of 1.5 cm on the bottom of the oral cavity,
together with an adjacent 3 cm submandibular lymph node;
histological diagnosis of the tumor was unavailable. Three
children’s uvulas had been removed as a traditional treat-
ment for cough.
The prevalence of caries in HIV-positive children varied
according to age, being 9% in children\2 years, 30% in 2-
to 3-year-olds, 50% in 3- to 4-year-olds, 91% in 4- to
5-year-olds, and 71% in children C5 years. The corre-
sponding figures among control children were 0, 17, 17, 57,
and 56%. HIV-related enlarged lymph nodes were most
Table 1 Characteristics of 78
HIV-positive and 78 control
children in Luanda
* p \ 0.05
** p \ 0.01
*** p \ 0.001
a For at least several hours daily
through public network
HIV children (%) Controls (%) p value
Median age in months (range) 51 (9–178) 49.5 (9–164)
Female 42 (54) 42 (54)
Median number of people in household 5 6 0.81
Malnourishment 21 (27) 12/77 (16) 0.08
Running water at home 24/77 (31) 28 (36) 0.53
Electricitya 61/77 (79) 61 (78) 0.88
Attending a vaccination program 70/76 (92) 61 (78) 0.02*
Malaria, earlier 72 (92) 73 (94) [0.99
Typhoid fever, earlier 18 (23) 21 (27) 0.61
Tuberculosis, now or earlier 22/77 (29) 2/77 (3) \0.0001***
Pneumonia 17 (22) 2 (3) 0.0003***
Diarrhea 2 (3) 5/77 (6) 0.44
Enlarged liver 8 (10) 0 0.007**
Enlarged spleen 3 (4) 0 0.25
Cardiac murmur 8 (10) 2 (3) 0.10
Developmental delay 3 (4) 1 (1) 0.62
Antibiotics at time of examination 61 (78) 13 (17) \0.0001***
Otorrhea, now or earlier 34 (44) 17 (22) 0.004**
Table 2
Otorhinolaryngological findings
in 78 HIV-positive and 78
control children in Luanda
* p \ 0.05
** p \ 0.01
*** p \ 0.001
a Mallampati score: tonsils at
least 25% of the space between
pillars
HIV children (%) Controls (%) p value
Skin lesions (eczema, molluscum contagiosum,
folliculitis)
25 (32) 4 (5) \0.0001***
Rhinorrhea 30 (38) 29 (37) [0.99
Angular cheilitis 2 (3) 0 0.50
Oral ulcerations 4 (5) 0 0.12
Dental caries 44 (56) 25 (32) 0.0009***
Oral candidiasis 9 (12) 5 (6) 0.40
Tonsil size C2?a 10 (13) 28 (37) 0.0009***
Hoarseness 5 (6) 3 (6) 0.72
Parotid enlargement 2 (3) 0 0.50
Preauricular fistule 2 (3) 2 (3) [0.99
Cervical lymphadenopathy [1 cm 35 (45) 8 (10) \0.0001***
Ear pain 44 (56) 27 (35) 0.006**
Acute otitis media 8 (10) 9 (12) [0.99
Chronic suppurative otitis media 21 (27) 3 (4) \0.0001***
Dry tympanic perforation 7 (9) 1 (1) 0.03*
Cerumen-impacted auditory canal 26 (33) 34 (44) 0.25
Any otorhinolaryngological pathology 72 (92%) 61 (78%) 0.02*
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frequently located in the upper jugular (66%), sub-
mandibular/submental (37%), and posterior cervical (31%)
zones.
Among the HIV children, the prevalence of CSOM
appeared highest (5/14; 36%) in children aged 0–2 years.
The disease was bilateral in 8/21 HIV-positive children
(38%), whereas all three cases in control children were
unilateral. Proteus vulgaris (9/17; 53%) and Pseudomonas
aeruginosa (4/17; 24%) proved the major causative agents
among the HIV children, and the one ear-discharge smear
obtained from a control child yielded P. aeruginosa.
Apart from otitis media and dry perforations (Table 2),
the HIV children exhibited a normal tympanum in 74/156
ears (47%), cerumen blockage in 32/156 ears (21%), and
tympanic retraction in 3/156 ears (2%). Control children
displayed a normal tympanum in 96/156 ears (62%),
cerumen blockage in 41/156 ears (26%), and tympanic
scarring in 1/156 ears (1%).
In the hearing evaluation (Table 3), 20 HIV-positive
children (26%) aged 15–140 months (median 65 months)
showed hearing loss: 10 cases (13%) were bilateral, of
which 5 (6%) at least a moderate degree. Of the control
children, 12 (15%) presented with elevated hearing
thresholds and one case (1%) appeared bilateral. The
background for HIV children’s hearing loss comprised
CSOM (12/30 ears; 40%), cerumen blockage (7/30; 23%),
dry tympanic perforation (5/30; 17%), undetermined (4/30;
13%), and tympanic retraction (2/30; 7%). In the control
group, hearing loss was related to cerumen blockage (5/13
ears; 38%), undetermined factors (5/13; 38%), AOM (2/13;
15%), and CSOM (1/13; 8%). Compared with the control
group, HIV-positive children were significantly more likely
to present with bilateral hearing impairment (p = 0.009).
Overall, the differences in status findings between the
ARV- and non-ARV-treated HIV-positive children were
not significant.
Discussion
Pathological ORL findings were very common in both
HIV-positive (92%) and HIV-negative (78%) children.
However, the profiles of typical ORL findings in these two
groups differed markedly. The HIV-associated ORL find-
ings comprised cervical lymphadenopathy, dermal lesions,
chronic otitis, small tonsils, dental caries, and hearing loss.
Although HIV positivity in children is increasing in
developing countries, only a few reports, including one
small prospective and comparative study, exist on ORL
findings in these children (Table 4) [2, 3, 14, 15].
The most usual HIV-associated ORL manifestation in
our study was cervical lymphadenopathy[1 cm, occurring
in nearly half of the HIV-positive children. This was not
surprising, as HIV-positive children are commonly known
to present with lymph node enlargement, especially in the
head and neck area, even if they are otherwise asymp-
tomatic [3, 13, 16]. However, 10% of the control children
also showed cervical lymph node swelling, making this
alone an unreliable sign of HIV positivity.
One-third of the HIV-positive children carried extensive
skin lesions, such as eczema and molluscum contagiosum,
which are the commonly known manifestations in HIV-
positive children and denote clinical disease stage 2 (mildly
symptomatic) [13]. The lack of skin problems in control
children further emphasizes the significance of skin lesions
as indicators of HIV positivity.
Table 3 Hearing thresholds of
78 HIV-positive and 78 control
children in Luanda
a Average hearing threshold of
500, 1,000, 2,000, and
4,000 Hz; performed on
children aged over 5 years
HIV group Control group
All ears
N = 156 (%)
Better-hearing
ears N = 78 (%)
All ears
N = 156 (%)
Better-hearing
ears N = 78 (%)
Brainstem auditory evoked potentials
40 dB 142 (91) 75 (96) 145 (93) 75 (96)
60 dB 8 (5) 1 (1) 4 (3)
80 dB 4 (3) 2 (3)
No response 2 (1)
Failed 7 (4) 3 (4)
Pure-tone audiometrya
B25 dB 39/58 (67) 22/29 (76) 53/62 (85) 30/31 (97)
26–40 dB 11/58 (19) 5/29 (17) 10/62 (15) 1/31 (3)
41–60 dB 5/58 (8) 1/29 (3)
61–80 dB 2/58 (3) 1/29 (3)
C81 dB
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Chronic otorrhea affected one-quarter of the HIV chil-
dren, especially those aged under 2 years. Previous studies
from developed and developing countries confirm the
association between HIV and chronic otitis [1–4, 14–18],
CSOM being categorized as a mild symptom of HIV [13].
Even though our control children also exhibited a relatively
high CSOM prevalence, the presence of chronic ear dis-
charge, especially bilateral, appeared strongly suggestive
of HIV positivity. In accordance with earlier studies, lower
respiratory tract infections, such as tuberculosis and
pneumonia, also appeared significantly more common in
our HIV-positive children [3, 6].
HIV-positive children exhibited significantly smaller
tonsils than control children. Previous studies on HIV-
positive children have mainly detected hypertrophy of the
adenotonsillar tissue [5, 15]; one study reported adenoidal
atrophy [19]. However, a series from Spain showed the
adenotonsillar tissue to initially enlarge, but to significantly
diminish as the disease progressed [20]. In our study,
clinical disease stage and tonsil size did not correlate.
Nevertheless, our HIV children’s generally small tonsil
size, as well as the absence of marked adenotonsillar
hypertrophy, may at least partially reflect their overall poor
clinical condition. Of note, parotid enlargement was pres-
ent in only 3% of the HIV children, which is equal to or
less than in earlier studies [2, 3, 6, 14–16].
Dental caries appeared a serious problem in all of the
children, particularly in the HIV-positive, whom it
affected not only more frequently, but also at a younger
age and with greater severity. Our result of 56% in the
HIV group is consistent with the previous reports of 58%
and 60% among pediatric HIV patients [8, 21]. Dental
health, even though comprising an entity apart from the
ORL field, markedly accounts for child’s quality of life
and should therefore be noted when examining the oral
cavity.
One-quarter of the HIV-positive children suffered from
hearing loss in one or both ears. Bilateral hearing impair-
ment, associated with HIV positivity, was present in over
10%. Our results are in accordance with previous studies
from Brazil, describing unilateral or bilateral hearing loss
in 23–37% of HIV-infected children [9, 10]. However,
these figures refer to children with hearing thresholds
above 15–20 dB, whereas our study applied less sensitive
criteria ([25 dB) for hearing loss. Consistent with the
aforementioned studies, the majority of our hearing
impairment cases were related to middle-ear infections.
A common dilemma in developing countries, cerumen
impaction [22], was also detected in our study in both
groups of children. After excluding the cases with contra-
lateral otitis or a history of ear pain, otorrhea, or ototoxic
drugs, cerumen remained the only apparent etiologic factor




























































































































































































































































































































































































































































































Eur Arch Otorhinolaryngol (2011) 268:1527–1532 1531
123
Conclusion
Our study showed ORL diseases to be significantly com-
mon in HIV-positive children. Routine evaluation of the
ORL area and hearing in these heavily burdened children
could substantially improve their quality of life.
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